We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.08B
AUM Growth
+$407M
Cap. Flow
+$226M
Cap. Flow %
4.45%
Top 10 Hldgs %
23.59%
Holding
154
New
18
Increased
54
Reduced
21
Closed
16

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$69.6M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$63M
3
MDB icon
MongoDB
MDB
+$59.3M
4
DV icon
DoubleVerify
DV
+$47.6M
5
FLYW icon
Flywire
FLYW
+$39.8M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$165M
2
DUOL icon
Duolingo
DUOL
+$33.1M
3
KURA icon
Kura Oncology
KURA
+$32.8M
4
COGT icon
Cogent Biosciences
COGT
+$30.6M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$25.8M

Sector Composition

Rank Sector Weight
1 Healthcare 38.81%
2 Technology 24%
3 Industrials 15.64%
4 Consumer Discretionary 5.21%
5 Utilities 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IEX icon
101
IDEX
IEX
$17.2B
$11.7M 0.23%
58,400
– –
ICPT
102
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$11.2M 0.22%
800,000
– –
SWAV
103
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$11M 0.22%
39,700
+16,100
+68% +$4.09M
BAX icon
104
Baxter International
BAX
$13.8B
$10.7M 0.21%
198,600
– –
YETI icon
105
Yeti Holdings
YETI
$3.76B
$10.5M 0.21%
369,000
– –
ADCT icon
106
ADC Therapeutics
ADCT
$141M
$9.06M 0.18%
1,879,959
– –
EHC icon
107
Encompass Health
EHC
$11B
$8.8M 0.17%
+194,495
New +$9.73M
ALXO icon
108
ALX Oncology
ALXO
$262M
$8.63M 0.17%
+902,000
New +$10.5M
PRAX icon
109
Praxis Precision Medicines
PRAX
$8.58B
$7.99M 0.16%
234,537
– –
WD icon
110
Walker & Dunlop
WD
$1.68B
$7.92M 0.16%
94,535
– –
EVH icon
111
Evolent Health
EVH
$358M
$7.79M 0.15%
216,700
– –
ELS icon
112
Equity Lifestyle Properties
ELS
$12.7B
$7.75M 0.15%
123,385
-38,215
-24% -$2.75M
GXO icon
113
GXO Logistics
GXO
$5.8B
$7.71M 0.15%
220,000
– –
APTV.PRA
114
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
$7.44M 0.15%
78,500
-16,000
-17% -$1.79M
EGP icon
115
EastGroup Properties
EGP
$11.3B
$7.33M 0.14%
50,800
– –
OPCH icon
116
Option Care Health
OPCH
$3.36B
$6.97M 0.14%
221,500
– –
BCAB icon
117
BioAtla
BCAB
$5.61M
$6.12M 0.12%
+15,900
New +$5.2M
AJG icon
118
Arthur J. Gallagher & Co
AJG
$65.9B
$5.81M 0.11%
+33,932
New +$6.02M
ROIV icon
119
Roivant Sciences
ROIV
$24.9B
$5.33M 0.1%
1,690,300
– –
SNV
120
DELISTED
Synovus
SNV
$5.23M 0.1%
139,487
-2,613
-2% -$104K
XPO icon
121
XPO
XPO
$23.4B
$5.12M 0.1%
193,545
– –
IONS icon
122
Ionis Pharmaceuticals
IONS
$8.85B
$4.87M 0.1%
110,000
– –
ZTS icon
123
Zoetis
ZTS
$31.9B
$4.56M 0.09%
+30,747
New +$5.14M
ARE icon
124
Alexandria Real Estate Equities
ARE
$9.15B
$4.53M 0.09%
32,335
-7,565
-19% -$1.16M
TRML
125
DELISTED
Tourmaline Bio
TRML
$4.11M 0.08%
156,109
– –
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Eventide Asset Management held 154 positions worth $5.08B, up 8.7% from $4.68B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $226M of net new capital in Q3 2022, opening 18 new positions and adding to 54 existing holdings. Its largest new stake was DoubleVerify: 1,847,144 shares worth $50.5M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Cogent Biosciences, an estimated $30.6M trimmed.

  • Eventide Asset Management's largest Q3 2022 buy was DoubleVerify: 1,847,144 shares worth $50.5M.
  • Eventide Asset Management added most to Doximity in Q3 2022, an estimated $69.6M increase.
  • Eventide Asset Management's biggest Q3 2022 reduction was Cogent Biosciences, cutting an estimated $30.6M.
  • Eventide Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $165M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $5.08B portfolio in Q3 2022.
  • Eventide Asset Management opened 18 new positions and closed 16 in Q3 2022.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $5.08B.

Based on Eventide Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.